Lisa Childress, PA
Surgical · Ironton, OHNPI 1659692176
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Organogenesis Inc. at 39.7% of the total. Reporting peaked in 2022 at $528 and has fallen 66.3% since, to $178 in 2025.
Across 51 payments — averaging $23.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$477
- Braeburn Inc.$163
- Amgen$126
- AbbVie$56
- Boehringer Ingelheim$48
- Novo Nordisk$45
- plus $287 from 14 others
What the payments were for
- Food & beverage$1,202100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 14 | $477 |
| Braeburn Inc. | 2 | $163 |
| Amgen | 9 | $126 |
| AbbVie | 3 | $56 |
| Boehringer Ingelheim | 3 | $48 |
| Novo Nordisk | 3 | $45 |
| Lilly USA, LLC | 3 | $44 |
| Titan Surgical Group, LLC | 1 | $35 |
| KCI USA, Inc. | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
| Smith+Nephew | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Collegium Pharmaceutical, Inc. | 1 | $13 |
| AstraZeneca | 1 | $13 |
How this compares
$1,202 in reported general payments places this provider in the 75th percentile of 294 surgical providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 29 | $215 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 30 | $140 |
| Oxycodone Hcl | 18 | $56 |
Paid to pharmacies, not to this prescriber.
Other surgical in Ironton
- Andrew BakerColumbus$102K
- Michael KuehneToledo$35K
- Joseph EhrhardCincinnati$14K
- Leigha GarringerColumbus$13K
- Brian StevensLorain$13K
- Anne KrogerDayton$10K
- James SabettaAkron$9K
- Monica SedmakCincinnati$7K
- Kerry NieDayton$7K
- Megan WhitehouseCincinnati$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.